HEALTH CATALYST, INC. (HCAT) Social Stream
HEALTH CATALYST INC (HCAT) Price Targets From Analysts
Use the tables below to see what analysts covering HEALTH CATALYST INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 10 | $70 | $43 | $61 | $12.89 | 373.24% |
| 2021-11-15 | 10 | $70 | $44 | $61.777 | $12.89 | 379.26% |
| 2021-12-02 | 10 | $70 | $44 | $60.111 | $12.89 | 366.34% |
| 2021-12-08 | 9 | $70 | $48 | $61.5 | $12.89 | 377.11% |
| 2021-12-20 | 9 | $70 | $48 | $59.875 | $12.89 | 364.51% |
| 2022-03-01 | 9 | $70 | $35 | $56 | $12.89 | 334.45% |
| 2022-03-03 | 9 | $66 | $31 | $50.125 | $12.89 | 288.87% |
| 2022-03-07 | 9 | $66 | $31 | $46.625 | $12.89 | 261.71% |
| 2022-03-09 | 9 | $60 | $31 | $45.875 | $12.89 | 255.9% |
| 2022-04-01 | 9 | $60 | $28 | $45.5 | $12.89 | 252.99% |
| 2022-04-14 | 10 | $60 | $28 | $44.777 | $12.89 | 247.38% |
| 2022-05-11 | 10 | $60 | $18 | $37.444 | $12.89 | 190.49% |
| 2022-05-23 | 11 | $60 | $17 | $29.25 | $12.89 | 126.92% |
| 2022-06-28 | 11 | $60 | $17 | $28.333 | $12.89 | 119.81% |
| 2022-08-02 | 11 | $39 | $17 | $25.416 | $12.89 | 97.18% |
| 2022-08-05 | 11 | $39 | $16 | $24.166 | $12.89 | 87.48% |
| 2022-08-09 | 10 | $39 | $15 | $22.5 | $12.89 | 74.55% |
| 2022-08-10 | 9 | $39 | $15 | $20.916 | $12.89 | 62.27% |
| 2022-09-13 | 11 | $39 | $11 | $20.083 | $12.89 | 55.8% |
| 2022-09-25 | 11 | $39 | $11 | $19.833 | $12.89 | 53.86% |
| 2022-09-26 | 11 | $39 | $11 | $19.5 | $12.89 | 51.28% |
| 2022-10-25 | 12 | $39 | $9 | $18.666 | $12.89 | 44.81% |
| 2022-10-31 | 13 | $39 | $9 | $18 | $12.89 | 39.64% |
| 2022-11-10 | 13 | $39 | $8 | $17 | $12.89 | 31.89% |
| 2022-11-15 | 13 | $39 | $8 | $16.923 | $12.89 | 31.29% |
| 2023-01-03 | 14 | $39 | $8 | $16.5 | $12.89 | 28.01% |
The Trend in the Analyst Price Target
HCAT's average price target has moved down $28.28 over the prior 38 weeks.
HCAT reports an average of 101.85% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-11 | 10 | 60 | 18 | 37.444 | 12.61 | 196.94% |
| 2022-05-11 | 11 | 60 | 17 | 35.400 | 12.61 | 180.73% |
| 2022-08-05 | 10 | 39 | 16 | 24.000 | 11.35 | 111.45% |
| 2022-09-25 | 11 | 39 | 11 | 19.833 | 9.34 | 112.34% |
| 2022-11-15 | 14 | 39 | 8 | 16.923 | 10.92 | 54.97% |
HCAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 7 | 0 | 7 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 15 months, HCAT's average broker recommendation rating worsened by 0.5.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HCAT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HEALTH CATALYST INC's variance in analysts' estimates is lower than -2877.65% of them.
- HCAT has a greater number of analysts covering the stock than 3013.19% of stocks in the mid market cap category.
- HCAT has a higher upside potential (average analyst target price relative to current price) than 2931.97% of stocks in the mid market cap category.
- In terms of how HEALTH CATALYST INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 1730.21% of that group.
Stocks similar to HEALTH CATALYST INC in the Business Services industry regarding analyst recommendations and price targets are DOYU, QTT, and MNTV.
View All Top Stocks by Price Target
Make investment decisions regarding HCAT using the data that counts. Try POWR Ratings for free.